News
Dr. Manel Esteller, Award for Innovation in the Healthcare Field in Oncology
Manel Esteller, Director of the Epigenetics and Cancer Biology Program at IDIBELL, ICREA Researcher and Professor of Genetics at the University of Barcelona, is the recipient of the Innovation Award in the Healthcare Field in Oncology, awarded by the Celgene Chair of Innovation in Health and the University of Alcalá. The award was given yesterday […]
ICABELL, a new boost to the internationalization of IDIBELL’s research
The Bellvitge Biomedical Research Institute has been awarded 176,734€ in order to carry out the “ICABELL – Internationalization of biomedical research on the Bellvitge Campus” project, whose main researcher is Dr. Josep Manuel Menchón. The aid is part of the Call for Boosting Actions: Europe Networks and Managers – Europe Technology Centers 2017, which is […]
Nobel Laureate Erwin Neher visits IDIBELL
The winner of the 1991 Nobel Prize for Medicine visits the institute and talks to its younger researchers Last Wednesday, February 21st, the Bellvitge Biomedical Research Institute (IDIBELL) welcomed professor Erwin Neher, Nobel Prize in Physiology or Medicine in 1991, to participate in an informal meeting with the pre and postdoctoral researchers of the institute. […]
RAC1 protein could be a new therapeutic target to fight neurodegeneration in Parkinson’s disease
A new research study reveals RAC1 protein could be a new therapeutic target to study the molecular mechanisms related to the neurodegenerative processes in Parkinson’s disease. The study, published in the online edition of the journal Molecular Neurobiology, is led by Antonella Consiglio, researcher at the Faculty of Medicine and Health Sciences of the University of Barcelona, the […]
Scientists prove the implication of an amino acid transporter in age-related deafness
The CIBERER U730 and U731 units, led respectively by Virginia Nunes (IDIBELL, UB) and Manuel Palacín (IRBB, UB) have just published in eLife a study carried out in collaboration with the U761 units (Isabel Varela-Nieto, CSIC / UAM) and U716 (Mara Dierssen, CRG), as well as with international groups, Dr. Meritxell Espino (Sidra Medicine, Qatar) and Dr. […]
The IT-LIVER European consortium expands TGF-beta knowledge in liver cancer
The research of the TGF-beta and cancer group of the Bellvitge Biomedical Research Institute (IDIBELL) within the IT-LIVER (Inhibiting TGF-beta in liver diseases) consortium, a collaborative European action coordinated by Dr. Isabel Fabregat, has led to three new impact publications that offer new insights into the molecular mechanisms associated with the cytokine TGF-beta in liver […]
Àlex Vaquero is awarded 200,000 euros from Worldwide Cancer Research to better understand the origin of cancer
Dr. Àlex Vaquero, leader of the chromatin biology research group of the Bellvitge Biomedical Research Institute (IDIBELL), has been awarded one of the prestigious grants from the Worldwide Cancer Research organization, worth 200,000 euros. The grant will fund a new project of this basic research group focused on the study of the mechanisms of tumor […]
EU empowers four IDIBELL researchers with Marie Sklodowska-Curie Individual Fellowships
Quatre ajuts concedits en la convocatòria amb més propostes presentades
The Cátedra Extraordinaria del Dolor honors Francisco Ciruela for the design of the first photoactive drug with analgesic action
Professor Francisco Ciruela, from the Faculty of Medicine and Health Sciences of the University of Barcelona, the Institute of Neurosciences of the UB and the Bellvitge Biomedical Research Institute (IDIBELL), has been awarded the Preclinical Research Award from Cátedra Extraordinaria del Dolor of the University of Salamanca – Grünenthal Foundation. This prize awards a research with animal models, published in the […]